Scandinavian Journal of Infectious Diseases · 1979 · 66 citations · 24 references
MedicineInfectious DiseasesInternal MedicineClinical ImmunologyHepatologyHepatotoxicologyChronic Liver DiseaseHepatic PathologyLiver DiseaseLiver Function TestsViral HepatitisChronic Viral HepatitisHepatitis A Virus InfectionHepatitis SerologyPrognostic VariablesSerological ClassificationSerological EpidemiologySerological ScreeningSerum Alanine Aminotransferase
Sera of 480 hospitalized hepatitis patients were tested for hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs) and to hepatitis B core antigen (anti-HBc), antibody to hepatitis A virus (anti-HAV) and anti-HAV of IgM-class. Serological markers indicating hepatitis A infection were found in 107 (22.3%) and markers indicating hepatitis B in 297 patients (61.9%), while 63 patients (13.1%) were classified as hepatitis type "non-A, non-B". The latter group mainly comprised drug addicts (50.8%), cases of post-transfusion hepatitis (11.1%) and patients without obvious hepatitis exposure (28.6%). In spite of these epidemiological similarities to hepatitis B, the maximum levels of serum alanine aminotransferase and bilirubin were comparable to those in patients with hepatitis A and significantly lower than in hepatitis B infection. Chronic hepatitis developed in 7.1% of the "non-A, non-B" patients, a figure close to that reported for hepatitis B.
24
A CLASSIFICATION OF CHRONIC HEPATITIS
J. De Groote, V. Desmet, P. Gedigk et al. · The Lancet · 1968 · 847 citations
J F BOURDILLON · The Lancet · 1964 · 444 citations